I attended the Cancer Genomics Symposium, hosted at UC Berkeley ( http://qb3.berkeley.edu/ccb/cancer-genomics-symposium/ …
). The speaker line-up was:
Welcome & Opening Remarks: Daniel Rokhsar, Organizer
Samuel Aparicio: Clonal Evolution and Cancer Medicine
Matthew Meyerson: Somatic Alterations in Human Cancer Genomes
Maria Figueroa: Using Genome-Wide Epigenomic Studies to Gain Insight into Mechanisms of Leukemogenesis
Esther Rheinbay: Epigenetic regulation of Tumor Initiation and Heterogeneity in Glioblastoma
David Haussler: Large-scale Cancer Genomics
Luis Diaz: Novel Clinical Applications of Somatic Cancer Mutations
P. Andrew Futreal: Cancer Genomics
My general take-home messages from the Symposium are:
- Cancers evolve, so treatments need to keep up
- Next-generation sequencing is a sensitive diagnostic tool and allows for earlier detection.
- Therapies can be fine-tuned as we understand patient-specific and tumor-specific signals.
Apologies for any misunderstandings, misspellings, or misattributions.